IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
96.87
-0.15 (-0.15%)
Dec 16, 2025, 4:00 PM EST - Market closed
IRADIMED CORPORATION Market Cap
IRADIMED CORPORATION has a market cap or net worth of $1.23 billion as of December 16, 2025. Its market cap has increased by 81.49% in one year.
Market Cap
1.23B
Enterprise Value
1.18B
1-Year Change
81.49%
Ranking
Category
Stock Price
$96.87
Market Cap Chart
Since July 16, 2014, IRADIMED CORPORATION's market cap has increased from $100.50M to $1.23B, an increase of 1,126.17%. That is a compound annual growth rate of 24.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 1.23B | 77.07% |
| Dec 31, 2024 | 697.00M | 16.48% |
| Dec 29, 2023 | 598.40M | 68.33% |
| Dec 30, 2022 | 355.50M | -37.66% |
| Dec 31, 2021 | 570.30M | 103.90% |
| Dec 31, 2020 | 279.70M | 4.17% |
| Dec 31, 2019 | 268.50M | 0.37% |
| Dec 31, 2018 | 267.50M | 67.29% |
| Dec 29, 2017 | 159.90M | 34.48% |
| Dec 30, 2016 | 118.90M | -61.68% |
| Dec 31, 2015 | 310.30M | 122.44% |
| Dec 31, 2014 | 139.50M | 38.81% |
| Jul 16, 2014 | 100.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.06B |
| Johnson & Johnson | 516.00B |
| AbbVie | 401.99B |
| UnitedHealth Group | 308.98B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 248.85B |
| Abbott Laboratories | 223.39B |